175 related articles for article (PubMed ID: 10620132)
1. The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity.
Yang F; Sarangarajan R; Le Poole IC; Medrano EE; Boissy RE
J Invest Dermatol; 2000 Jan; 114(1):157-64. PubMed ID: 10620132
[TBL] [Abstract][Full Text] [Related]
2. Effects of 4-tertiary butylphenol on the tyrosinase activity in human melanocytes.
Yang F; Boissy RE
Pigment Cell Res; 1999 Aug; 12(4):237-45. PubMed ID: 10454291
[TBL] [Abstract][Full Text] [Related]
3. Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation.
Hariharan V; Klarquist J; Reust MJ; Koshoffer A; McKee MD; Boissy RE; Le Poole IC
J Invest Dermatol; 2010 Jan; 130(1):211-20. PubMed ID: 19657355
[TBL] [Abstract][Full Text] [Related]
4. Sulfur containing tyrosine analogs can cause selective melanocytotoxicity involving tyrosinase-mediated apoptosis.
Minamitsuji Y; Toyofuku K; Sugiyama S; Yamada K; Jimbow K
J Investig Dermatol Symp Proc; 1999 Sep; 4(2):130-6. PubMed ID: 10536987
[TBL] [Abstract][Full Text] [Related]
5. Rhododendrol, a depigmentation-inducing phenolic compound, exerts melanocyte cytotoxicity via a tyrosinase-dependent mechanism.
Sasaki M; Kondo M; Sato K; Umeda M; Kawabata K; Takahashi Y; Suzuki T; Matsunaga K; Inoue S
Pigment Cell Melanoma Res; 2014 Sep; 27(5):754-63. PubMed ID: 24890809
[TBL] [Abstract][Full Text] [Related]
6. DeoxyArbutin and its derivatives inhibit tyrosinase activity and melanin synthesis without inducing reactive oxygen species or apoptosis.
Chawla S; Kvalnes K; deLong MA; Wickett R; Manga P; Boissy RE
J Drugs Dermatol; 2012 Oct; 11(10):e28-34. PubMed ID: 23134995
[TBL] [Abstract][Full Text] [Related]
7. Pigment content of cultured human melanocytes does not correlate with tyrosinase message level.
Naeyaert JM; Eller M; Gordon PR; Park HY; Gilchrest BA
Br J Dermatol; 1991 Oct; 125(4):297-303. PubMed ID: 1720016
[TBL] [Abstract][Full Text] [Related]
8. On the etiology of contact/occupational vitiligo.
Boissy RE; Manga P
Pigment Cell Res; 2004 Jun; 17(3):208-14. PubMed ID: 15140065
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the catalytic activity of preexisting tyrosinase in black and Caucasian human melanocyte cell cultures.
Fuller BB; Spaulding DT; Smith DR
Exp Cell Res; 2001 Jan; 262(2):197-208. PubMed ID: 11139343
[TBL] [Abstract][Full Text] [Related]
10. Effects of commonly used mitogens on the cytotoxicity of 4-tertiary butylphenol to human melanocytes.
Yang F; Abdel-Malek Z; Boissy RE
In Vitro Cell Dev Biol Anim; 1999; 35(10):566-70. PubMed ID: 10614865
[TBL] [Abstract][Full Text] [Related]
11. Abnormal translocation of tyrosinase and tyrosinase-related protein 1 in cutaneous melanocytes of Hermansky-Pudlak Syndrome and in melanoma cells transfected with anti-sense HPS1 cDNA.
Sarangarajan R; Budev A; Zhao Y; Gahl WA; Boissy RE
J Invest Dermatol; 2001 Sep; 117(3):641-6. PubMed ID: 11564171
[TBL] [Abstract][Full Text] [Related]
12. A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: Implications for vitiligo.
Manga P; Sheyn D; Yang F; Sarangarajan R; Boissy RE
Am J Pathol; 2006 Nov; 169(5):1652-62. PubMed ID: 17071589
[TBL] [Abstract][Full Text] [Related]
13. Tyrosinase may protect human melanocytes from the cytotoxic effects of the superoxide anion.
Valverde P; Manning P; Todd C; McNeil CJ; Thody AJ
Exp Dermatol; 1996 Oct; 5(5):247-53. PubMed ID: 8981022
[TBL] [Abstract][Full Text] [Related]
14. Contribution of melanogenic proteins to the heterogeneous pigmentation of human melanocytes.
Abdel-Malek Z; Swope V; Collins C; Boissy R; Zhao H; Nordlund J
J Cell Sci; 1993 Dec; 106 ( Pt 4)():1323-31. PubMed ID: 8126111
[TBL] [Abstract][Full Text] [Related]
15. (-)-N-Formylanonaine from Michelia alba as a human tyrosinase inhibitor and antioxidant.
Wang HM; Chen CY; Chen CY; Ho ML; Chou YT; Chang HC; Lee CH; Wang CZ; Chu IM
Bioorg Med Chem; 2010 Jul; 18(14):5241-7. PubMed ID: 20584613
[TBL] [Abstract][Full Text] [Related]
16. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
[TBL] [Abstract][Full Text] [Related]
17. Tyrosinase induction and inactivation in normal cultured human melanocytes by endothelin-1.
Monji A; Inoue H; Oshima H; Aihara M; Tomioka M; Kumagai N
Int J Tissue React; 2005; 27(2):41-9. PubMed ID: 16035647
[TBL] [Abstract][Full Text] [Related]
18. Arbutin: mechanism of its depigmenting action in human melanocyte culture.
Maeda K; Fukuda M
J Pharmacol Exp Ther; 1996 Feb; 276(2):765-9. PubMed ID: 8632348
[TBL] [Abstract][Full Text] [Related]
19. Comparison of in vitro cytotoxicity of N-acetyl and N-propionyl derivatives of phenolic thioether amines in melanoma and neuroblastoma cells and the relationship to tyrosinase and tyrosine hydroxylase enzyme activity.
Gili A; Thomas PD; Ota M; Jimbow K
Melanoma Res; 2000 Feb; 10(1):9-15. PubMed ID: 10711635
[TBL] [Abstract][Full Text] [Related]
20. Depigmentation caused by application of the active brightening material, rhododendrol, is related to tyrosinase activity at a certain threshold.
Kasamatsu S; Hachiya A; Nakamura S; Yasuda Y; Fujimori T; Takano K; Moriwaki S; Hase T; Suzuki T; Matsunaga K
J Dermatol Sci; 2014 Oct; 76(1):16-24. PubMed ID: 25082450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
